Division of Gastrointestinal Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu, China (mainland).
Med Sci Monit. 2023 Mar 30;29:e939442. doi: 10.12659/MSM.939442.
BACKGROUND Studies have revealed that having systemic inflammation is linked to worse survival rates across a range of malignancies. This study aimed to evaluate the predictive significance of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) in combination with fibrinogen-to-albumin ratio (FAR) in surgical patients with colorectal adenocarcinoma (CRC). MATERIAL AND METHODS From January 2010 to December 2016, 200 patients with CRC had their preoperative NLR, PLR, LMR, and FAR assessed. Following that, univariate and multivariate analytic techniques were used to establish the prognostic value of these 4 indicators. Plotting the receiver operating characteristic (ROC) curves allowed researchers to assess whether the NLR-FAR, PLR-FAR, and LMR-FAR could be applied to predict survival. RESULTS High preoperative NLR (≥3.9 vs <3.9, P<0.001), high preoperative PLR (≥106 vs <106, P=0.039), low preoperative LMR (≥4.2 vs <4.2, P<0.001), and high preoperative FAR (≥0.09 vs <0.09, P=0.028) were significantly associated with worse overall survival in multivariate analysis, which was also confirmed with survival curves. The prediction outcomes of the combined components outperformed those of a single index. NLR-FAR outperformed PLR-FAR and LMR-FAR as a predictor of CRC, with an area under the curve (AUC) of 97.24% (95% confidence interval (CI)=0.9535 to 0.9915, P<0.0001), 92.57% (95% CI=0.8880 to 0.9634, P<0.0001), and 90.26% (95% CI=0.8515 to 0.9538, P<0.0001). CONCLUSIONS In patients with CRC, preoperative NLR, PLR, LMR, and FAR can be utilized as independent predictors of overall survival. Additionally, in the combined detection findings, NLR and FAR performed better as predictors of CRC patients than PLR-FAR and LMR-FAR.
研究表明,全身性炎症与多种恶性肿瘤的生存率降低有关。本研究旨在评估中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、淋巴细胞与单核细胞比值(LMR)联合纤维蛋白原与白蛋白比值(FAR)在结直肠癌(CRC)手术患者中的预测意义。
本研究回顾性分析了 2010 年 1 月至 2016 年 12 月期间 200 例 CRC 患者的术前 NLR、PLR、LMR 和 FAR 值。采用单因素和多因素分析技术确定这 4 项指标的预后价值。绘制受试者工作特征(ROC)曲线,以评估 NLR-FAR、PLR-FAR 和 LMR-FAR 是否可用于预测生存。
多因素分析显示,术前 NLR(≥3.9 与<3.9,P<0.001)、PLR(≥106 与<106,P=0.039)、LMR(≥4.2 与<4.2,P<0.001)和 FAR(≥0.09 与<0.09,P=0.028)升高与总生存期较差显著相关,生存曲线也证实了这一点。联合成分的预测结果优于单一指标。NLR-FAR 作为 CRC 的预测指标优于 PLR-FAR 和 LMR-FAR,曲线下面积(AUC)分别为 97.24%(95%CI=0.9535 至 0.9915,P<0.0001)、92.57%(95%CI=0.8880 至 0.9634,P<0.0001)和 90.26%(95%CI=0.8515 至 0.9538,P<0.0001)。
在 CRC 患者中,术前 NLR、PLR、LMR 和 FAR 可作为总生存期的独立预测指标。此外,在联合检测结果中,NLR 和 FAR 作为 CRC 患者的预测指标优于 PLR-FAR 和 LMR-FAR。